ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,961Medicare Part D Prescriptions Filled, Including Refills

Rank: 93 out of 3647

$1.39M Total Retail Price of All Prescriptions

Rank: 93 out of 3647

577 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
94% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 577 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

3% of this provider’s 577 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

3% of this provider’s 24,876 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

47 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
OMEPRAZOLE 1,080 993 1 3
AMLODIPINE BESYLATE 976 929 2 2
SIMVASTATIN 913 879 3 1
LEVOTHYROXINE SODIUM 616 590 4 5
LISINOPRIL 591 509 5 4
FUROSEMIDE 586 542 6 8
DONEPEZIL HCL 565 550 7 30
NAMENDA 538 538 8 49
CLOPIDOGREL 511 500 9 26
METOPROLOL TARTRATE 508 495 10 7
POTASSIUM CHLORIDE 465 439 11 24
IBUPROFEN 374 309 12 55
SILVER SULFADIAZINE 358 358 10 13 243
RANITIDINE HCL 356 334 14 29
FAMOTIDINE 355 320 15 61
MEGESTROL ACETATE 342 311 R 16 138
CARVEDILOL 326 305 17 20
PLAVIX 322 305 18 39
LACTULOSE 314 297 19 128
NOVOLIN 70-30 297 280 20 130
GABAPENTIN 290 221 21 17
MUPIROCIN 285 261 22 137
DIGOXIN 272 260 23 51
QUETIAPINE FUMARATE 272 265 23 89
METFORMIN HCL 270 230 25 6
CLONIDINE HCL 252 233 26 46
CLOTRIMAZOLE-BETAMETHASONE 245 224 27 84
NEXIUM 244 223 28 44
AMMONIUM LACTATE 244 234 28 141
TRAZODONE HCL 242 204 30 64
CRESTOR 241 228 31 19
INSULIN SYRINGE 234 214 32 76
ATENOLOL 229 205 33 10
METOPROLOL SUCCINATE 219 205 34 18
CARBIDOPA-LEVODOPA 216 216 35 127
NOVOLOG MIX 70-30 204 182 36 261
TRAMADOL HCL 201 165 37 22
DIOVAN 201 194 37 40
LANTUS 199 181 39 59
LIDODERM 191 171 40 108
NIFEDIPINE ER 190 179 41 67
PAROXETINE HCL 188 162 42 60
RISPERIDONE 178 126 43 83
ENALAPRIL MALEATE 174 165 44 35
KETOCONAZOLE 171 154 45 132
TAMSULOSIN HCL 171 159 45 28
ZOLPIDEM TARTRATE 163 162 47 14
SSD 163 163 47 310
ADVAIR DISKUS 160 153 49 52
AZITHROMYCIN 158 150 50 34
ISOSORBIDE MONONITRATE ER 156 156 51 56
METOCLOPRAMIDE HCL 153 132 52 135
HYDROCHLOROTHIAZIDE 153 145 52 9
SURE COMFORT 148 145 54 161
GLIPIZIDE 145 123 55 41
MECLIZINE HCL 142 141 56 85
NOVOLIN R 141 129 57 139
GLYBURIDE-METFORMIN HCL 139 138 R 58 94
ATORVASTATIN CALCIUM 132 118 59 13
CITALOPRAM HBR 130 105 60 25
PROAIR HFA 129 101 61 62
ESCITALOPRAM OXALATE 123 123 62 65
BENZTROPINE MESYLATE 117 56 R 63 222
DICYCLOMINE HCL 115 104 64 194
TRIAMCINOLONE ACETONIDE 112 112 65 136
PANTOPRAZOLE SODIUM 110 110 66 38
SERTRALINE HCL 110 96 66 27
ALENDRONATE SODIUM 109 109 68 23
LOSARTAN POTASSIUM 108 100 69 11
GLYBURIDE 103 103 R 70 54
SEROQUEL 100 100 71 185
DIOVAN HCT 98 98 72 80
NITROGLYCERIN PATCH 97 94 73 203
NORTRIPTYLINE HCL 97 97 73 273
VOLTAREN 94 82 75 102
DICLOFENAC SODIUM 94 81 75 86
PENTOXIFYLLINE 92 81 77 180
BENAZEPRIL HCL 84 74 78 71
LOVASTATIN 84 84 78 21
LANSOPRAZOLE 80 79 80 116
PRAVASTATIN SODIUM 78 60 81 16
EXELON 78 78 81 129
LEVETIRACETAM 78 78 81 122
AMLODIPINE BESYLATE-BENAZEPRIL 75 75 84 74
CELEBREX 74 72 85 111
CARAFATE 73 73 86 410
PREDNISONE 73 61 86 43
MELOXICAM 72 67 88 33
CLOTRIMAZOLE 71 69 89 375
SINGULAIR 69 69 90 90
PHENYTOIN SODIUM EXTENDED 68 57 91 199
CIPROFLOXACIN HCL 68 66 91 53
ALLOPURINOL 68 67 91 37
ALBUTEROL SULFATE 67 66 94 157
NAPROXEN 66 54 95 70
SUCRALFATE 65 63 96 219
DILTIAZEM 24HR CD 64 64 97 155
HALOPERIDOL 64 39 97 358
LATANOPROST 63 59 99 218
HYDRALAZINE HCL 62 46 100 81
LEXAPRO 62 62 100 177
DIVALPROEX SODIUM 62 34 100 131
GEMFIBROZIL 60 43 103 82
ACTOS 59 59 104 148
MIRTAZAPINE 59 47 104 63
METRONIDAZOLE 58 57 106 247
ACETAMINOPHEN-CODEINE 58 58 S3 106 149
CLOBETASOL PROPIONATE 56 56 108 188
ALPRAZOLAM 56 56 108 31
SEROQUEL XR 55 53 110 252
GLIMEPIRIDE 54 54 111 45
SPIRONOLACTONE 54 54 111 77
KLOR-CON M10 53 51 113 227
TRICOR 53 40 113 144
MONTELUKAST SODIUM 51 51 115 160
VALPROIC ACID 51 51 115 331
LUMIGAN 50 50 117 291
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 9, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.